In-vitro activity of lytic peptides alone and in combination with macrolides and inhibitors of dihydrofolate reductase against Pneumocystis carinii

Journal of Antimicrobial Chemotherapy

Volumn 42, Issue 4, 1998, Pages 445-451

  Cirioni, Oscar ^a,b   Giacometti, Andrea ^a   Barchiesi, Francesco ^a   Scalise, Giorgio ^a  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^b Azienda Ospedaliera Umberto I   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; AZITHROMYCIN; CECROPIN; CLARITHROMYCIN; DIAVERIDINE; DIHYDROFOLATE REDUCTASE INHIBITOR; INDOLICIDIN; MACROLIDE; MAGAININ 2; POLYPEPTIDE ANTIBIOTIC AGENT; PYRIMETHAMINE; RANALEXIN; ROXITHROMYCIN; SULFAMETHOXAZOLE; SULFONAMIDE; TRIMETHOPRIM; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; CULTURE MEDIUM; CYST; DOSE RESPONSE; IN VITRO STUDY; INOCULATION; MICROBIAL GROWTH; NONHUMAN; PARASITE SURVIVAL; PNEUMOCYSTIS CARINII; PNEUMOCYSTOSIS; TROPHOZOITE;

ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; ANTIMICROBIAL CATIONIC PEPTIDES; DRUG SYNERGISM; FOLIC ACID ANTAGONISTS; HUMANS; MACROLIDES; MICROBIAL SENSITIVITY TESTS; PEPTIDES; PEPTIDES, CYCLIC; PNEUMOCYSTIS; XENOPUS PROTEINS;

EID: 0031689899     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/42.4.445     Document Type: Article

References (22)

1. Lane, H. C., Laughon, B. E., Falloon, J., Kovacs, J. A., Davey, R. T., Polis, M. A. et al. (1994). Recent advances in the management of AIDS-related opportunistic infections. Annals of Internal Medicine 120, 945-55.
2. Cushion, M. T., Chen, F. & Kloepfer, N. (1997). A cytotoxicity assay for evaluation of candidate anti-Pneumocystis carinii agents. Antimicrobial Agents and Chemotherapy 41, 379-84.
3. Andreu, D., Merrifield, R. B., Steiner, H. & Boman, H. G. (1985). N-terminal analogues of cecropin A: synthesis, antibacterial activity, and conformational properties. Biochemistry 24, 1683-8.
4. Sawyer, J. G., Martin, N. L. & Hancock, R. E. W. (1988). Interaction of macrophage cationic proteins with the outer membrane of Pseudomonas aeruginosa. Infection and Immunity 56, 693-8.
5. Lehrer, R. I., Barton, A., Daher, K. A., Harwig, S. S. L., Ganz, T. & Selsted, M. E. (1989). Interaction of human defensins with Escherichia coli. Mechanism of bactericidal activity. Journal of Clinical Investigation 84, 553-61.
6. Blondelle, S. E. & Houghton, R. A. (1991). Hemolytic and antimicrobial activities of the twenty-four individual omission analogues of melittin. Biochemistry 30, 4671-8.
7. Aley, S. B., Zimmerman, M., Hetsko, M., Selsted, M. E. & Gillin, F. D. (1994). Killing of Giardia lamblia by cryptdins and cationic neutrophil peptides. Infection and Immunity 62, 5397-403.
8. Falla, T. J. & Hancock, R. E. W. (1997). Improved activity of a synthetic indolicidin analog. Antimicrobial Agents and Chemotherapy 41, 771-5.
9. Hancock, R. E. W. (1997). Antibacterial peptides and the outer membranes of Gram-negative bacilli. Journal of Medical Microbiology 46, 1-3.
10. Zasloff, M. (1987). Magainins, a class of antimicrobial peptides from Xenopus skin: isolation, characterization of two active forms, and partial cDNA sequence of a precursor. Proceedings of the National Academy of Sciences of the USA 84, 5449-53.
11. Boman, H. G. & Hultmark, D. (1987). Cell-free immunity in insects. Annual Review of Microbiology 41, 103-26.
12. Lee, J. Y., Boman, A., Sun, C. X., Andersson, M., Jörvall, H., Mutt, V. et al. (1989). Antibacterial peptides from pig intestine: isolation of a mammalian cecropin. Proceedings of the National Academy of Sciences of the USA 86, 9159-62.
13. Clark, D. P., Durell, S., Maloy, W. L. & Zasloff, M. (1994). Ranalexin. A novel antimicrobial peptide from bullfrog (Rana catasbeiana) skin, structurally related to the bacterial antibiotic polymyxin. Journal of Biological Chemistry 269, 10,849-55.
14. Cannon, M. (1987). Antimicrobial peptides. A family of wound healers. Nature 328, 478.
15. Wade, D., Boman, A., Wåhlin, B., Drain, C. M., Andreu, D., Boman, H. G. et al. (1990). AII-D amino acid-containing channel-forming antibiotic peptides. Proceedings of the National Academy of Sciences of the USA 87, 4761-5.
16. DeLucca, A. J., Blond, J. M., Jacks, T. J., Grimm, C., Cleveland, T. E. & Walsh, T. J. (1997). Fungicidal activity of cecropin A. Antimicrobial Agents and Chemotherapy 41, 481-3.
17. Walzer, P. D., Foy, J., Steele, P. & White, M. (1992). Treatment of experimental pneumocystosis: review of 7 years of experience and development of a new system for classifying antimicrobial drugs. Antimicrobial Agents and Chemotherapy 36, 1943-50.
18. Alder, J., Mitten, M., Shipkowitz, N., Hernandez, L., Hui, Y., Marsh, K. et al. (1994). Treatment of experimental Pneumocystis carinii infection by combination of clarithromycin and sulpha-methoxazole. Journal of Antimicrobial Chemotherapy 33, 253-63.
19. Cirioni, O., Giacometti, A. & Scalise, G. (1997). In-vitro activity of atovaquone, sulphamethoxazole and dapsone alone and combined with inhibitors of dihydrofolate reductase and macrolides against Pneumocystis carinii. Journal of Antimicrobial Chemotherapy 39, 45-51.
20. Bevins, C. L. & Zasloff, M. (1990). Peptides from frog skin. Annual Review of Biochemistry 59, 395-414.
21. Vaara, M. & Porro, M. (1996). Group of peptides that act synergistically with hydrophobic antibiotics against Gram-negative enteric bacteria. Antimicrobial Agents and Chemotherapy 40, 1801-5.
22. Viljanen, P., Matsunaga, H., Kimura, Y. & Vaara, M. (1991). The outer membrane permeability-increasing action of deacylpolymyxins. Journal of Antibiotics 44, 517-23.